Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-027277

Director sold 796 shares at $248.81 ($198,053)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

De Witte Jan · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-12 Sale : show line 1 in the form 10b5-1 −796 $248.81 $198,053 6,723 D
Open-market sales · 796 sh · avg $248.81 · $198,053
Loading xslF345X05/form4.xml…